We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$44.4B
1-Year Est. Return
36.05%
This Fund
S&P 500
This Quarter
Est. Return
+8.05%
1 Year Est. Return
+36.05%
3 Year Est. Return
+84.6%
5 Year Est. Return
+116.4%
10 Year Est. Return
+513.43%
AUM
$39.1B
AUM Growth
+$3.66B
(+10%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
4.07%
Top 10 Holdings %
Top 10 Hldgs %
42.13%
Holding
715
New
115
Increased
243
Reduced
238
Closed
61
Avg Time Held Equity + Options
9.9
quarters
Top 10 Avg Time Held Equity + Options
12.9
quarters
Top 20 Avg Time Held Equity + Options
21.1
quarters
Avg Time Held Equity only
9.9
quarters
Top 10 Avg Time Held Equity only
12.9
quarters
Top 20 Avg Time Held Equity only
21.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$633M |
| 2 |
Meta Platforms (Facebook)
META
|
+$424M |
| 3 |
Apple
AAPL
|
+$157M |
| 4 |
Microsoft
MSFT
|
+$154M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$995M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$97.9M |
| 3 |
Wells Fargo
WFC
|
+$81.6M |
| 4 |
Lam Research
LRCX
|
+$76.2M |
| 5 |
Woodward
WWD
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.45% |
| 2 | Healthcare | 24.28% |
| 3 | Communication Services | 11.56% |
| 4 | Financials | 10.17% |
| 5 | Consumer Discretionary | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.97T
| $2.55B | 6.51% |
5,267,686
+308,087
| +6% | +$154M |
2013 Q2
50 quarters
|
|
|
2
Alphabet (Google) Class A
GOOGL
$4.3T
| $2.09B | 5.34% |
6,671,591
-342,538
| -5% | -$97.9M |
2015 Q4
40 quarters
|
|
|
3
Meta Platforms (Facebook)
META
$1.83T
| $1.92B | 4.91% |
2,908,562
+635,655
| +28% | +$424M |
2018 Q1
31 quarters
|
|
|
4
Apple
AAPL
$4.91T
| $1.82B | 4.66% |
6,707,117
+584,276
| +10% | +$157M |
2013 Q2
50 quarters
|
|
|
5
Lam Research
LRCX
$399B
| $1.6B | 4.09% |
9,344,080
-489,931
| -5% | -$76.2M |
2019 Q3
25 quarters
|
|
6
Johnson & Johnson
JNJ
$630B
| $1.47B | 3.75% |
7,089,139
+273,944
| +4% | +$54.2M |
2013 Q2
50 quarters
|
|
|
7
Amazon
AMZN
$2.83T
| $1.47B | 3.75% |
6,353,413
+2,766,500
| +77% | +$633M |
2018 Q3
29 quarters
|
|
|
8
Thermo Fisher Scientific
TMO
$243B
| $1.4B | 3.57% |
2,412,063
+270,200
| +13% | +$153M |
2024 Q2
6 quarters
|
|
9
Salesforce
CRM
$189B
| $1.09B | 2.78% |
4,104,033
+293,398
| +8% | +$72.9M |
2020 Q3
21 quarters
|
|
10
Broadcom
AVGO
$1.73T
| $1.09B | 2.78% |
3,136,731
+325,982
| +12% | +$117M |
2021 Q1
19 quarters
|
|
11
Abbott
ABT
$172B
| $1.06B | 2.72% |
8,482,553
+306,069
| +4% | +$39M |
2013 Q2
50 quarters
|
|
12
US Bancorp
USB
$88.9B
| $982M | 2.51% |
18,401,004
+642,057
| +4% | +$31.6M |
2017 Q2
34 quarters
|
|
13
Accenture
ACN
$128B
| $972M | 2.48% |
3,621,269
+267,415
| +8% | +$67.9M |
2013 Q2
50 quarters
|
|
14
Visa
V
$724B
| $929M | 2.38% |
2,649,557
+209,569
| +9% | +$71.4M |
2017 Q3
33 quarters
|
|
15
Elevance Health
ELV
$89.5B
| $887M | 2.27% |
2,531,090
+7,640
| +0.3% | +$2.58M |
2013 Q2
50 quarters
|
|
16
UnitedHealth
UNH
$340B
| $881M | 2.25% |
2,670,159
+3,536
| +0.1% | +$1.2M |
2013 Q2
50 quarters
|
|
17
Texas Instruments
TXN
$259B
| $848M | 2.17% |
4,887,820
+233,687
| +5% | +$40M |
2016 Q2
38 quarters
|
|
18
Eli Lilly
LLY
$1.05T
| $794M | 2.03% |
739,274
+38,666
| +6% | +$37M |
2013 Q2
50 quarters
|
|
19
Merck
MRK
$359B
| $723M | 1.85% |
6,870,145
+244,795
| +4% | +$23M |
2016 Q3
37 quarters
|
|
20
Hilton Worldwide
HLT
$73.5B
| $672M | 1.72% |
2,340,013
+323,262
| +16% | +$88M |
2020 Q2
22 quarters
|
|
21
Intuitive Surgical
ISRG
$150B
| $672M | 1.72% |
1,185,910
+46,251
| +4% | +$24.6M |
2022 Q2
14 quarters
|
|
22
KLA
KLAC
$255B
| $618M | 1.58% |
5,087,570
+701,560
| +16% | +$82.3M |
2017 Q3
33 quarters
|
|
23
Coca-Cola
KO
$379B
| $616M | 1.57% |
8,808,478
+1,822,090
| +26% | +$127M |
2013 Q2
50 quarters
|
|
24
TJX Companies
TJX
$153B
| $583M | 1.49% |
3,798,519
+146,304
| +4% | +$21.6M |
2013 Q2
50 quarters
|
|
25
Cigna
CI
$74.6B
| $539M | 1.38% |
1,958,134
+323,786
| +20% | +$90.8M |
2020 Q4
20 quarters
|
|
Similar funds
GAM
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2025 Portfolio in Review
As of Q4 2025, Grantham, Mayo, Van Otterloo & Co (GMO) held 715 positions worth $39.1B, up 10% from $35.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO) deployed $1.59B of net new capital in Q4 2025, opening 115 new positions and adding to 243 existing holdings. Its largest new stake was The Magnum Ice Cream Company N.V.: 2,219,681 shares worth $35.2M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Oracle, an estimated $995M trimmed.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 2,219,681 shares worth $35.2M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Amazon in Q4 2025, an estimated $633M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2025 reduction was Oracle, cutting an estimated $995M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited AvidXchange in Q4 2025, selling an estimated $28.2M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 42% of its $39.1B portfolio in Q4 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 115 new positions and closed 61 in Q4 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 10% quarter-over-quarter to $39.1B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2025, filed 17 Feb 2026.